Cynthia Pussinen
Chief Executive Officer presso SERNOVA CORP.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Cynthia Pussinen is currently the Chief Executive Officer & Director at Sernova Corp.
Prior to her current position, she served as the Chief Technical Officer at Spark Therapeutics, Inc. from 2021 to 2022.
She also held the position of Executive Vice President-Technical Development at Actinium Pharmaceuticals, Inc. Ms. Pussinen holds a graduate degree from Rensselaer Polytechnic Institute and an undergraduate degree from the University of Connecticut.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SERNOVA CORP.
-.--% | 05/09/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Cynthia Pussinen
| Società | Posizione | Inizio |
|---|---|---|
| SERNOVA CORP. | Chief Executive Officer | 05/09/2023 |
Precedenti posizioni note di Cynthia Pussinen
| Società | Posizione | Fine |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2022 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Cynthia Pussinen
| Rensselaer Polytechnic Institute | Graduate Degree |
| University of Connecticut | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SERNOVA CORP. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Cynthia Pussinen
